贾号;
JIA Hao;First People's Hospital of Shangqiu;

• 1:商丘市第一人民医院

摘要(Abstract)：

目的探讨耐甲氧西林金黄色葡萄球菌(MRSA)肺部感染伴低蛋白血症患者使用替考拉宁时,对替考拉宁血药浓度、药动学参数和临床疗效的影响。方法选取2018年1～12月我院重症监护病房收治的44例MRSA肺部感染伴低蛋白血症(白蛋白<25 g·L^(-1))患者,将其分为两组,A组(14例)给予替考拉宁起始6 mg·kg(-1))患者,将其分为两组,A组(14例)给予替考拉宁起始6 mg·kg^(-1)q12h×3次维持6 mg·kg(-1)q12h×3次维持6 mg·kg^(-1)qd治疗,B组(14例)给予起始12 mg·kg(-1)qd治疗,B组(14例)给予起始12 mg·kg^(-1)q12h×3次维持12 mg·kg(-1)q12h×3次维持12 mg·kg^(-1)qd治疗,蛋白水平正常者为对照组(16例),给予起始6 mg·kg(-1)qd治疗,蛋白水平正常者为对照组(16例),给予起始6 mg·kg^(-1)q12h×3次维持6 mg·kg(-1)q12h×3次维持6 mg·kg^(-1)qd治疗。分析比较3组患者治疗后的血药浓度、AUC_(0-24)/MIC和临床疗效。结果第6剂给药前30 min,A组替考拉宁血浓度显著低于对照组(P<0.01)、B组替考拉宁的血药浓度与对照组无统计学差异。A组患者的AUC_(0-24)/MIC及AUC_(0-24)/MIC≥345(%)显著低于对照组(P<0.01),而B组与对照组均无统计学差异。A组、B组替考拉宁的CL和Vd均显著高于对照组(P<0.01)。A组疗效低于对照组(P<0.05),B组与对照组差异无统计学意义(P>0.05)。结论低蛋白血症会降低替考拉宁的血药浓度、AUC_(0-24)/MIC,降低临床疗效,并且低蛋白血症患者的肌酐清除率和表观分布容积显著增加。通过提高剂量,可提高替考拉宁的血药浓度、AUC_(0-24)/MIC,增加临床疗效。
OBJECTIVE To investigate the effects of teicoplanin on blood concentration,pharmacokinetic parameters and clinical efficacy in patients with meticillin-resistant Staphylococcus aureus(MRSA) pulmonary infection and hypoproteinemia. METHODS 44 patients with lung infection with MRSA and hypoalbuminemia in ICU from Jan.2018 to Dec.,2018 were divided into two groups. Group A was gave 6 mg·kg(-1)qd治疗。分析比较3组患者治疗后的血药浓度、AUC_(0-24)/MIC和临床疗效。结果第6剂给药前30 min,A组替考拉宁血浓度显著低于对照组(P<0.01)、B组替考拉宁的血药浓度与对照组无统计学差异。A组患者的AUC_(0-24)/MIC及AUC_(0-24)/MIC≥345(%)显著低于对照组(P<0.01),而B组与对照组均无统计学差异。A组、B组替考拉宁的CL和Vd均显著高于对照组(P<0.01)。A组疗效低于对照组(P<0.05),B组与对照组差异无统计学意义(P>0.05)。结论低蛋白血症会降低替考拉宁的血药浓度、AUC_(0-24)/MIC,降低临床疗效,并且低蛋白血症患者的肌酐清除率和表观分布容积显著增加。通过提高剂量,可提高替考拉宁的血药浓度、AUC_(0-24)/MIC,增加临床疗效。
OBJECTIVE To investigate the effects of teicoplanin on blood concentration,pharmacokinetic parameters and clinical efficacy in patients with meticillin-resistant Staphylococcus aureus(MRSA) pulmonary infection and hypoproteinemia. METHODS 44 patients with lung infection with MRSA and hypoalbuminemia in ICU from Jan.2018 to Dec.,2018 were divided into two groups. Group A was gave 6 mg·kg^(-1)12-hourly intravenously for 3 times followed by 6 mg·kg(-1)12-hourly intravenously for 3 times followed by 6 mg·kg^(-1) once daily,group B was gave 12 mg·kg(-1) once daily,group B was gave 12 mg·kg^(-1)12-hourly intravenously for 3 times followed by 12 mg·kg(-1)12-hourly intravenously for 3 times followed by 12 mg·kg^(-1) once daily,the control group with normal protein levels,was gave 6 mg·kg(-1) once daily,the control group with normal protein levels,was gave 6 mg·kg^(-1)12-hourly intravenously for 3 times followed by 6 mg·kg(-1)12-hourly intravenously for 3 times followed by 6 mg·kg^(-1) once daily. After treatment,the serum drug concentration,AUC_(0-24)/MIC and clinical efficacy of the three groups were analyzed and compared. RESULTS Before 30 min,the 6 th dose was administered,the blood concentration of teicoplanin,AUC_(0-24)/MIC,and AUC_(0-24)/MIC ≥125(%) in group A were significantly lower than that in the control group(P<0.01),while there was no statistical difference between group B and the control group. The CL and Vd of group A and group B were significantly higher than that of the control group(P<0.01). Compared with the control group,the clinical efficacy of group A was significantly reduced,while there was no statistical difference between group B and the control group. CONCLUSION Hypoproteinemia can reduce the blood drug concentration and AUC_(0-24)/MIC of teicolanine,and the clinical efficacy,and significantly increase the creatinine clearance rate and apparent volume of distribution in patients with hypoproteinemia. By increasing the dose,the blood concentration and AUC_(0-24)/MIC and the clinical efficacy of teicolanin can be increased.

关键词(KeyWords)： 替考拉宁;耐甲氧西林金黄色葡萄球菌;低蛋白血症;血药浓度
teicoplanin;methicillin-resistant Staphylococcus aureus;hypoproteinemia;blood drug concentration

Abstract:

Keywords:

基金项目(Foundation):

作者(Authors): 贾号;
JIA Hao;First People's Hospital of Shangqiu;

参考文献(References)：

• [1]Finfer S,Bellomo R,Mc Evoy S,et al.Effect of baseline serum albumin concentration on outcome of resuscitation with albumin or saline in patients in intensive care units:analysis of data from the saline versus Albumin Fluid Evaluation(SAFE)study[J].BMJ,2006,333(7507):1044-1049．
• [2]李湘燕,吕媛．低蛋白血症对危重症患者抗菌药物疗效的影响[J]．中华呼吸与结核杂志．2018,41(8):600-604．
• [3]Ulldemolins M,Roberts J A,Rello J,et al.The effects of hypoal buminaemia on optimizing antibiotic dosing in critically ill patients[J].Clin Pharmacokinet,2011,50(4):99-110．
• [4]Mimoz O,Rolland D,Adoun M,et al.Steady state trough serum and epithelial lining fluid concentrations of teicoplanin 12 mg/kg per day in patients with ventilator-associated pneumonia[J].Intensive Care Med,2006,32(8):775-779．
• [5]Yano R,Nakamura T,Tsukamoto H,et al.Variability in teicoplanin protein binding and its prediction using serum albumin concentrations[J].The Drug Monit,2007,29(4):399-403．
• [6]Safavi M,Honarmand A.The impact ofadmission hyperglycemia or hypoalbuminemia on need ventilator,time ventilated,mortality,and morbidity in critically ill trauma patients[J].Ulus Travma Acil Cerrahi Derg,2009,15(2):120-129．
• [7]高景,邢丽华,高炜,等．替考拉宁治疗老年患者MRSA肺部感染21例疗效观察[J]．中华医院感染学杂志,2010,20(5):714-716．
• [8]李小波,元占中,甘庆,等．替考拉宁与去甲万古霉素在医院获得性MRSA肺炎老年患者治疗中的临床研究[J]．中华医院感染学杂志,2011,21(14):3023-3025．
• [9]替考拉宁临床应用剂量专家共识组．替考拉宁临床应用剂量中国专家共识[J]．中华结核和呼吸杂志,2016,39(7):500-507．
• [10]Kuti J L,Kiffer C R,Mendes C M,et al.Pharmacodynamic comparison of linezolid,teicoplanin and vancomycin against clinical isolates of Staphylococcus aureus and coagulase-negative staphylococci collected from hospitals in Brazil[J].Clin Microbiol Infect,2008,14(3):116-123．
• [11]Yano R,Nakamura T,Tsukamoto H,et al.Variability in teicoplanin protein binding and its prediction using serum albuminconcentrations[J].Ther Drug Monit,2007,29(4):399-403．
• [12]Roberts J A,Stove V,De Waele J J,et al.Variability in protein binding of teicoplanin and achievement of therapeutic drug monitoring targets in critically ill patients:lessons from the DALI Study[J].Int J Antimicrob Agents,2014,43(5):423-430．
• [13]Roberts J A,Pea F,Lipman J.The clinical relevance of plasma protein binding changes[J].Clin Pharmacokinet,2013,52(1):1-8．
• [14]Brink A J,Richards G A,Lautenbach E E,et al.Albumin concentration significantly impacts on free teicoplanin plasma concentrations in non-critically ill patients with chronic bone sepsis[J].Int JAntimicrob Agents,2015,45(6):647-651．
• [15]杨丽莎,刘畅,胡健．替考拉宁药动力学指导重症G+球菌感染患者个体化用药的临床研究[J]．中华肺部疾病杂志,2019,12(1):53-58.